The Motley Fool EN

Asset Manager Exits Shares of Hims & Hers Health

Hims & Hers Health has struggled, but it just inked a new partnership with Novo Nordisk.

Mar 10, 2026 &03071010202631; 20:07 UTC www.fool.com Trending 3/5

Read original on www.fool.com ↗

→

Neutral impact

Sentiment score: -15/100

Moderate impact Short-term (days)

WHAT THIS MEANS

Hims & Hers Health faces headwinds as an asset manager exits its shares, though the company secured a strategic partnership with Novo Nordisk for GLP-1 drug distribution. This mixed signal suggests investor caution despite the positive partnership development.

AI CONFIDENCE

65% High

SENTIMENT GAUGE

NEWS POWER SCORE

AFFECTED ASSETS

⇅

HIMS

HIMSStock

High volatility expected

Asset manager exit signals weakness, but Novo Nordisk partnership provides growth catalyst for telehealth GLP-1 distribution

↑

Novo Nordisk

NVOStock

Expected to rise

Partnership expansion with Hims strengthens distribution network for GLP-1 medications

PRICE HISTORY

Loading chart...

⚡ SUGGESTED ACTION

Monitor HIMS for stabilization around the Novo Nordisk partnership announcement. Consider entry on weakness if partnership gains traction, but wait for institutional accumulation signals before committing capital.

KEY SIGNALS

Institutional investor exit indicates confidence concernsNovo Nordisk partnership validates business modelGLP-1 market opportunity remains strongMixed institutional sentiment on HIMS valuation

SECTORS INVOLVED

HealthcareTelehealthPharmaceuticals

Analysis generated on Mar 11, 2026 at 00:35 UTC

Disclaimer: This analysis is generated by artificial intelligence for informational purposes only and does not constitute financial advice, investment recommendation, or solicitation. Original reporting by The Motley Fool. Always conduct your own research and consult a qualified financial advisor before making investment decisions.

Asset Manager Exits Shares of Hims & Hers Health

RELATED INTELLIGENCE